2fzk: Difference between revisions

New page: left|200px<br /><applet load="2fzk" size="450" color="white" frame="true" align="right" spinBox="true" caption="2fzk, resolution 2.50Å" /> '''The Structure of Wil...
 
No edit summary
Line 1: Line 1:
[[Image:2fzk.gif|left|200px]]<br /><applet load="2fzk" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:2fzk.gif|left|200px]]<br /><applet load="2fzk" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="2fzk, resolution 2.50&Aring;" />
caption="2fzk, resolution 2.50&Aring;" />
'''The Structure of Wild-Type E. Coli Aspartate Transcarbamoylase in Complex with Novel T State Inhibitors at 2.50 Resolution'''<br />
'''The Structure of Wild-Type E. Coli Aspartate Transcarbamoylase in Complex with Novel T State Inhibitors at 2.50 Resolution'''<br />


==Overview==
==Overview==
Escherichia coli aspartate transcarbamoylase (ATCase) catalyzes the, committed step in pyrimidine nucleotide biosynthesis, the reaction between, carbamoyl phosphate (CP) and l-aspartate to form N-carbamoyl-l-aspartate, and inorganic phosphate. The enzyme exhibits homotropic cooperativity and, is allosterically regulated. Upon binding l-aspartate in the presence of a, saturating concentration of CP, the enzyme is converted from the, low-activity low-affinity T state to the high-activity high-affinity R, state. The potent inhibitor N-phosphonacetyl-l-aspartate (PALA), which, combines the binding features of Asp and CP into one molecule, has been, shown to induce the allosteric transition to the R state. In the presence, of only CP, the enzyme is the T structure with the active site primed for, the binding of aspartate. In a structure of the enzyme-CP complex (T(CP)), two CP molecules were observed in the active site approximately 7A apart, one with high occupancy and one with low occupancy. The high occupancy, site corresponds to the position for CP observed in the structure of the, enzyme with CP and the aspartate analogue succinate bound. The position of, the second CP is in a unique site and does not overlap with the aspartate, binding site. As a means to generate a new class of inhibitors for ATCase, the domain-open T state of the enzyme was targeted. We designed, synthesized, and characterized three inhibitors that were composed of two, phosphonacetamide groups linked together. These two phosphonacetamide, groups mimic the positions of the two CP molecules in the T(CP) structure., X-ray crystal structures of ATCase-inhibitor complexes revealed that each, of these inhibitors bind to the T state of the enzyme and occupy the, active site area. As opposed to the binding of Asp in the presence of CP, or PALA, these inhibitors are unable to initiate the global T to R, conformational change. Although the best of these T-state inhibitors only, has a K(i) value in the micromolar range, the structural information with, respect to their mode of binding provides important information for the, design of second generation inhibitors that will have even higher affinity, for the active site of the T state of the enzyme.
Escherichia coli aspartate transcarbamoylase (ATCase) catalyzes the committed step in pyrimidine nucleotide biosynthesis, the reaction between carbamoyl phosphate (CP) and l-aspartate to form N-carbamoyl-l-aspartate and inorganic phosphate. The enzyme exhibits homotropic cooperativity and is allosterically regulated. Upon binding l-aspartate in the presence of a saturating concentration of CP, the enzyme is converted from the low-activity low-affinity T state to the high-activity high-affinity R state. The potent inhibitor N-phosphonacetyl-l-aspartate (PALA), which combines the binding features of Asp and CP into one molecule, has been shown to induce the allosteric transition to the R state. In the presence of only CP, the enzyme is the T structure with the active site primed for the binding of aspartate. In a structure of the enzyme-CP complex (T(CP)), two CP molecules were observed in the active site approximately 7A apart, one with high occupancy and one with low occupancy. The high occupancy site corresponds to the position for CP observed in the structure of the enzyme with CP and the aspartate analogue succinate bound. The position of the second CP is in a unique site and does not overlap with the aspartate binding site. As a means to generate a new class of inhibitors for ATCase, the domain-open T state of the enzyme was targeted. We designed, synthesized, and characterized three inhibitors that were composed of two phosphonacetamide groups linked together. These two phosphonacetamide groups mimic the positions of the two CP molecules in the T(CP) structure. X-ray crystal structures of ATCase-inhibitor complexes revealed that each of these inhibitors bind to the T state of the enzyme and occupy the active site area. As opposed to the binding of Asp in the presence of CP or PALA, these inhibitors are unable to initiate the global T to R conformational change. Although the best of these T-state inhibitors only has a K(i) value in the micromolar range, the structural information with respect to their mode of binding provides important information for the design of second generation inhibitors that will have even higher affinity for the active site of the T state of the enzyme.


==About this Structure==
==About this Structure==
2FZK is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] with ZN, EOZ and CTP as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Aspartate_carbamoyltransferase Aspartate carbamoyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.1.3.2 2.1.3.2] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2FZK OCA].  
2FZK is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] with <scene name='pdbligand=ZN:'>ZN</scene>, <scene name='pdbligand=EOZ:'>EOZ</scene> and <scene name='pdbligand=CTP:'>CTP</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Aspartate_carbamoyltransferase Aspartate carbamoyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.1.3.2 2.1.3.2] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2FZK OCA].  


==Reference==
==Reference==
Line 14: Line 14:
[[Category: Escherichia coli]]
[[Category: Escherichia coli]]
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: Cardia, J.P.]]
[[Category: Cardia, J P.]]
[[Category: Eldo, J.]]
[[Category: Eldo, J.]]
[[Category: Heng, S.]]
[[Category: Heng, S.]]
[[Category: Kantrowitz, E.R.]]
[[Category: Kantrowitz, E R.]]
[[Category: Stieglitz, K.A.]]
[[Category: Stieglitz, K A.]]
[[Category: Xia, J.]]
[[Category: Xia, J.]]
[[Category: CTP]]
[[Category: CTP]]
Line 27: Line 27:
[[Category: xray structures]]
[[Category: xray structures]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Wed Nov 21 10:51:53 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:26:41 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA